Risk of colorectal cancer after weight loss in the obese: a pooled cohort study
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Losing weight after obesity can significantly lower colorectal cancer (CRC) risk. Optimal weight loss for reducing CRC risk is between 15-20%.
Area Of Science
- Oncology
- Epidemiology
- Public Health
Background
- Obesity is a known risk factor for colorectal cancer (CRC).
- The effect of weight loss on CRC risk in individuals with obesity remains unclear.
- Understanding this relationship is crucial for public health strategies targeting cancer prevention.
Purpose Of The Study
- To investigate the association between weight loss following obesity and the risk of developing colorectal cancer.
- To determine the optimal amount of weight loss for reducing CRC risk in individuals with obesity.
Main Methods
- Pooled analysis of data from the Multiethnic Cohort, Nurses' Health Study, and Health Professionals Follow-Up Study.
- Included adults aged 45-75 with at least three body mass index (BMI) measurements.
- Utilized group-based trajectory modeling for BMI and accelerated failure time models for CRC incidence.
Main Results
- Weight loss in individuals with severe obesity was associated with a longer duration free of CRC across various racial groups, except Hispanic/Latinos.
- Among individuals with obesity who lost weight, higher percentages of weight loss correlated with longer CRC-free duration.
- A weight loss of 15-20% demonstrated the most significant association with reduced CRC risk (AF 1.53, P<0.001).
Conclusions
- Weight loss post-obesity is linked to a reduced risk of colorectal cancer in diverse populations.
- Achieving 15-20% weight loss appears to be optimal for mitigating CRC risk in individuals with obesity.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...